Accessibility Tools

Skip to main content
Please donate today!

Covid Vaccine Compensation Reform

10 July 2026
Find Your Representative
Find Your Senator
How To Talk To Your Representatives

Tagged:

 Vaccine Injury Reporting

Did You Know, you can’t sue the manufacturer for a COVID-19 vaccine injury?

Unlike nearly every other product in the U.S., COVID-19 vaccines and other emergency counter measures are shielded from liability. Injured individuals have no right to sue the manufacturer—even in cases of clear harm. Instead, they’re forced into a little-known federal program called the Countermeasures Injury Compensation Program (CICP).

The problem? CICP is failing.

It operates behind closed doors, offers no legal representation, no appeals process, and pays almost nothing. While the Vaccine Injury Compensation Program (VICP) has awarded billions to those injured by vaccines like MMR and flu, the CICP has awarded 51—out of thousands of applicants. The rejection rate is 98.6%.

Pro-vaccine experts and advocates agree: CICP needs urgent reform. It's time for Congress to act.

Total Awarded Cases
12,000
8,000
4,000
51 Cases
12,848
Cases
CICP
(COVID-19 vaccines)¹
VICP
(all vaccines since 1988)²
Total Awarded Funds
$5 Billion
$2.5 Billion
$6.9
Million
$5.5
Billion
CICP
(COVID-19 vaccines)¹
VICP
(all vaccines since 1988)²
Within CICP's $6.9M total:
$5.94M — 1 claim
$1.0M — the other 50 claims combined

¹ CICP claims compensated for COVID-19 vaccines specifically (51 claims, $6.94M). Excludes other CICP-covered countermeasures (e.g., remdesivir, ventilators), which are compensated at inconsistent rates. Source: HRSA, CICP Data, Table 4, as of April 1, 2026 — hrsa.gov/cicp/cicp-data/table-4.

² VICP lifetime totals across all vaccines covered since 1988. COVID-19 vaccines are not eligible for VICP — injured individuals are instead routed to CICP, which is the core disparity this chart illustrates. Source: HRSA, VICP Data and Statistics, report dated March 1, 2026 — hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-03-01-26.pdf.

³ The single outlier is a Thrombosis with Thrombocytopenia Syndrome (TTS) claim, per HRSA Table 4.

CICP v. VICP Comparison

Separate ≠ Equal
CICP FundVICP Fund
Filing Deadline
1 Year
3 Years
Approval Rate
1.4%
49.3%
Judicial Process
No
Yes
Attorney and Expert Fees
No
Yes
Pain and Suffering
No
Yes
Attainable Standard of Truth
No
Yes
Neutral Fact Finder (Special Masters)
No
Yes
Transparent / Reviewable Decision Basis
No
Yes
Judicial Appellate Review
No
Yes

React19 maintains that the CICP is fundamentally inadequate for addressing injuries from emergency-use products. Legislative reform is urgently needed to align it more closely with the VICP.

This position reflects input from the vaccine-injured, manufacturers, and leading legal experts. We must learn from the COVID-19 response to strengthen the nation's emergency preparedness for future public health challenges.

Vaccine Injury Compensation Modernization Act of 2026

Providing a reasonable remedy to those harmed during a national health emergency isn't just important — it's a moral and constitutional imperative that upholds public trust and accountability. The Vaccine Injury Compensation Modernization Act of 2026 is bipartisan legislation introduced by Representatives Lloyd Doggett (D-TX) and Lloyd Smucker (R-PA). It modernizes the National Vaccine Injury Compensation Program by:  

Expanded Access & Filing Flexibility
  • Expand existing VICP filing window from 3 years to 5 years.
Fair Standards for Proving Injuries
  • Presumes similar criteria as the already functioning VICP: a presumption of causation. (The CICP imposes a near-impossible evidentiary standard)
  • Allows a one-time opening for current and rejected COVID vaccine CICP claims to re-file with the VICP.
  • Allows a one-time opening for COVID vaccine claims to be filed that have NOT previously filed in the CICP.
Comprehensive Compensation
  • Increase compensation to reflect today's economy.
  • Allow lost earnings, medical expenses, pain and suffering.
  • Death benefit increase to $600,000.

** Award amounts have not changed since 1986. CICP only allows medical expenses and lost earnings, with a cap of $50,000 for earnings and $370,000 for death.

Legal Representation & Appeals
  • Claimants have the right to attorney representation.
  • Denied claims can be appealed to federal courts.

**CICP does not cover attorney fees, nor can denied claims be appealed.

Dedicated Funding
  • Increases vaccine tax to the manufacturer from $.75 per vaccine to $2.20 per vaccine.
  • ** CICP is taxpayer funded, VICP is vaccine manufacturer funded.
Improves VICP Capacity
  • Requires at least 10 Special Masters (judges) to hear vaccine cases.
  • Improves reporting requirements on case backlogs and hearing schedules.
  • Provides Congress with better information to ensure timely claim resolution.
  • ** CICP does not have independent judicial process, the VICP has needed more special masters for years.

"The countermeasures program['s] largely invisible decisions are 'an incrutable enigma,' said Brain Abramson, an expert on vaccine law." - L.A. Times

Send a Letter To Your Representative

How the CICP Program is Performing

Total Awards:
As of July 1, 2026, 98.6% of applications have been rejected.

Applications:
Only 1/3 of React19’s membership have applied to the program. 41% don’t know what the program even is.

Have you filed for the CICP program?
YES
NO
32%
41%
27%
Don’t know what
this program is.
*COVID-19 vaccine injured surveyed Feb–Mar 2023.
CICP Application Rejection Rate
Accepted
98.6%
Rejected
*Current CICP applications processed as of April 2026.



React19 Struggling to Fill the Gap: To date, the U.S. Government have awarded under 51 applicants Covid vaccine injury CICP claims. The average payout is under $5,000. React19 has awarded over $1.9 million in medical grants, for out-of-pocket medical expenses, with donations from everyday Americans. 

*React19 is a volunteer organization dedicated to providing physical, financial, and emotional healing to those suffering adverse events after Covid vaccination.

CICP Shortfalls In Depth Look

Limited Benefits: Compensation is limited to documented, unreimbursed medical expenses and lost wages. Wages are capped at $50,000. ** Typical legal injury claims allow consideration to help the victim be financially restored: no cap on lost wages, pain and suffering awards, covered expenses to adjust with extended life care plan.

Filing Deadline: CICP claims must be filed within one year of vaccine administration. No exceptions. It often takes over a year for the vaccine injured to get diagnosed appropriately, and many others are unaware of the program’s existence until after the short one-year deadline has passed.

Finder of Fact and Law:The CICP, as a delegate of the Secretary of Health and Human Services (HHS), determines the merit of vaccine injured claims. The same agency is responsible for reviewing and deciding CICP claims. There is no independent party involved in evaluating whether a claim has merit.

Appeals and Judicial Review: If a CICP claim is denied, there is no option to appeal the decision and no court or independent body that can review it. The agency's singular and initial decision is final.

Standard of Proof: The CICP requires the vaccine injured (without any legal or expert representation to prove that the vaccine directly caused their illness. As COVID vaccine injuries are novel in nature, sufficient scientific evidence simply does yet exist and won't exist for years for the injured to prove their case. And as highlighted above, even the few adverse reactions that are listed on the FDA's vaccine package insert have been denied claims by this program.

Why is this urgent? – Needs Currently Not Met

Loss of Work & Income

Medical Supplies / Home Provisions

Housing/Rent Payments

Medical Care Expenses

Take Action

Passing the Vaccine Injury Compensation Modernization Act of 2026 will bring relief to those left behind by the pandemic and strengthen our preparedness for future emergencies.

Contact your U.S. Representative and Senators

In The News

Sources
● HRSA, Countermeasures Injury Compensation Program (CICP) Data, aggregate data as of April 1, 2026 — www.hrsa.gov/cicp/cicp-data
● HRSA, CICP Data, Table 4 — CICP Claims Compensated (Fiscal Years 2010–2026), as of April 1, 2026 — www.hrsa.gov/cicp/cicp-data/table-4 (totals for the 51 compensated COVID-19 vaccine claims calculated from the published per-claim table)
● HRSA, National Vaccine Injury Compensation Program (VICP) Data and Statistics, report dated March 1, 2026 — www.hrsa.gov/vaccine-compensation/data
● Congressional Research Service, CICP/VICP comparison — www.crsreports.congress.gov/product/pdf/LSB/LSB10584
● React19 internal figures: $2.0M in medical hardship grants to members (provided by React19)